newsfilter
← Latest News
GlobeNewswire·

SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences

NORTH PALM BEACH, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced a strategic investment in ARMR Sciences, a clinical-stage biodefense